Structures by: Saraçoĝlu H.
Total: 8
N-(1,3-Benzothiazol-2-yl)-4-(dimethylamino)benzylamine
C16H15N3S
Acta Crystallographica Section E (2004) 60, 11 o2090-o2092
a=11.7771(8)Å b=22.6876(12)Å c=11.7725(9)Å
α=90.00° β=116.822(5)° γ=90.00°
1-[3-Methyl-3-(2,4,6-trimethylphenyl)cyclobutyl]-2-(thiomorpholin-4-yl)ethanone
C20H29NOS
Acta Crystallographica Section E (2005) 61, 8 o2401-o2402
a=13.4594(10)Å b=9.8855(5)Å c=14.0878(11)Å
α=90.00° β=91.080(6)° γ=90.00°
3-[(2,4-Dinitrophenyl)hydrazono]butan-2-one oxime
C10H11N5O5
Acta Crystallographica Section E (2004) 60, 8 o1307-o1309
a=10.1400(16)Å b=12.3079(19)Å c=10.6624(18)Å
α=90.000° β=110.950(12)° γ=90.000°
(Benzofuran-2-yl)(3-methyl-3-phenylcyclobutyl)methanone
C20H18O2
Acta Crystallographica Section C (2004) 60, 7 o509-o510
a=6.1497(7)Å b=14.6894(19)Å c=16.922(2)Å
α=90.00° β=92.600(10)° γ=90.00°
N^1^-(4-tert-Butylphenyl)-N^2^-hydroxy-α-oxo-α-phenylacetamidine
C18H20N2O2
Acta Crystallographica Section C (2004) 60, 9 o702-o704
a=6.4331(10)Å b=10.7150(15)Å c=12.299(2)Å
α=75.054(12)° β=82.120(12)° γ=77.258(11)°
N^1^-(4-nitrophenyl)-N^2^-hydroxy-α-oxo-α-phenylacetamidine hemihydrate
C14H11N3O4,0.5H2O
Acta Crystallographica Section C (2004) 60, 9 o702-o704
a=6.8298(5)Å b=15.5454(15)Å c=26.097(2)Å
α=90.00° β=92.080(7)° γ=90.00°
N^1^-(2,6-Dimethylphenyl)-N^2^-hydroxy-α-oxo-α-phenylacetamidine
C16H16N2O2
Acta Crystallographica Section C (2004) 60, 2 o115-o117
a=8.1002(10)Å b=7.8837(10)Å c=23.108(3)Å
α=90° β=90.828(10)° γ=90°
Diacetatobis(2-aminobenzothiazole-κN)cobalt(II)
C18H18CoN4O4S2
Acta Crystallographica Section C (2005) 61, 7 m342-m343
a=8.3049(4)Å b=27.1833(16)Å c=8.9868(5)Å
α=90.00° β=90.00° γ=90.00°